Home
Live Updates
BPGbio to accelerate pancreatic cancer drug after promising initial trials : comparemela.com
BPGbio to accelerate pancreatic cancer drug after 'promising' initial trials
BPGbio, an AI-powered biopharma that focuses on oncology, neurology, and rare diseases, is advancing its pancreatic cancer drug BPM 31510 IV after a positive phase 1 and 2a study.
Related Keywords
,
Madappa Kundranda ,
Nivenr Narain ,
Banner Md Anderson Cancer Center ,
Beth Israel Medical Center Harvard School ,
Advisory Board ,
Interrogative Biology ,
Cancer Center ,
Project Survival ,
Beth Israel Medical ,
Harvard Medical School ,
Bio Developments ,
Pipelines ,
Emerging Markets ,
Pancreatic Cancer ,
Dancer ,
Ncology ,
Clinical Trials ,
comparemela.com © 2020. All Rights Reserved.